Skip to main content
Top
Published in: Nutrition & Metabolism 1/2012

Open Access 01-12-2012 | Brief communication

Salt overload in fructose-fed insulin-resistant rats decreases paraoxonase-1 activity

Authors: Waleska Cláudia Dornas, Wanderson Geraldo de Lima, Rinaldo Cardoso dos Santos, Melina Oliveira de Souza, Maísa Silva, Mirla Fiuza Diniz, Marcelo Eustáquio Silva

Published in: Nutrition & Metabolism | Issue 1/2012

Login to get access

Abstract

Paraoxonase 1 (PON1) is a HDL-associated esterase/lactonase and its activity is inversely related to the risk of cardiovascular diseases. The aim of the present study was to evaluate the effect of a high-salt diet on serum PON1 activity in fructose-fed insulin-resistant rats. Adult male Fischer rats were initially divided into two groups. Control (CON), which received a normal salt diet and drinking water throughout the study; high fructose (HF), which received a normal salt diet and 20% fructose supplemented drinking water. After 10 weeks, half of the animals from HF group were randomly switched to a high-salt diet and 20% fructose supplemented drinking water (HFS) for more 10 weeks. Serum PON1 activity was determined by synthetic substrate phenyl acetate. HFS rats showed markedly decreased PON1 activity (HFS rats, 44.3 ± 14.4 g/dL versus CON rats, 64.4 ± 13.3 g/dL, P < 0.05) as compared to controls. In parallel, the level of oxidative stress, as indicated by thiobarbituric acid reactive substances (TBARS), was increased in HFS rats by 1.2-fold in the liver in relation to controls and was negatively correlated with PON activity. Differential leukocyte counts in blood showed a significant change in lymphocytes and monocytes profile. In conclusion, these results show that PON1 activity is decreased in fructose-fed insulin-resistant rats on a high-salt diet, which may be associated with increased oxidative stress, leading to inflammation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mertens A, Holvoet P: Oxidized LDL and HDL: antagonists in atherogenesis. FASEB J. 2001, 15: 2073-2084. 10.1096/fj.01-0273rev.CrossRef Mertens A, Holvoet P: Oxidized LDL and HDL: antagonists in atherogenesis. FASEB J. 2001, 15: 2073-2084. 10.1096/fj.01-0273rev.CrossRef
2.
go back to reference Durrington PN, Mackness B, Mackness MI: Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2001, 21: 473-480. 10.1161/01.ATV.21.4.473.CrossRef Durrington PN, Mackness B, Mackness MI: Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2001, 21: 473-480. 10.1161/01.ATV.21.4.473.CrossRef
3.
go back to reference Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM: The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res. 2004, 45: 993-1007. 10.1194/jlr.R400001-JLR200.CrossRef Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM: The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res. 2004, 45: 993-1007. 10.1194/jlr.R400001-JLR200.CrossRef
4.
go back to reference Richter RJ, Jarvik GP, Furlong CE: Paraoxonase 1 status as a risk factor for disease or exposure. Adv Exp Med Biol. 2010, 660: 29-35. 10.1007/978-1-60761-350-3_4.CrossRef Richter RJ, Jarvik GP, Furlong CE: Paraoxonase 1 status as a risk factor for disease or exposure. Adv Exp Med Biol. 2010, 660: 29-35. 10.1007/978-1-60761-350-3_4.CrossRef
5.
go back to reference Précourt LP, Amre D, Denis MC, Lavoie JC, Delvin E, Seidman E, Levy E: The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis. 2011, 214: 20-36. 10.1016/j.atherosclerosis.2010.08.076.CrossRef Précourt LP, Amre D, Denis MC, Lavoie JC, Delvin E, Seidman E, Levy E: The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis. 2011, 214: 20-36. 10.1016/j.atherosclerosis.2010.08.076.CrossRef
6.
go back to reference Silva M, Lima WG, Silva ME, Pedrosa ML: Effect of streptozotocin on the glycemic and lipid profiles and oxidative stress in hamsters. Arq Bras Endocrinol Metabol. 2011, 55: 46-53. 10.1590/S0004-27302011000100006.CrossRef Silva M, Lima WG, Silva ME, Pedrosa ML: Effect of streptozotocin on the glycemic and lipid profiles and oxidative stress in hamsters. Arq Bras Endocrinol Metabol. 2011, 55: 46-53. 10.1590/S0004-27302011000100006.CrossRef
7.
go back to reference Alp H, Varol S, Celik MM, Altas M, Evliyaoglu O, Tokgoz O, Tanrıverdi MH, Uzar E: Protective effects of beta glucan and glicazide on brain tissue and sciatic nerve of diabetic rats induced by streptozonin. Exp Diabetes Res. 2012, 2012: 230342-CrossRef Alp H, Varol S, Celik MM, Altas M, Evliyaoglu O, Tokgoz O, Tanrıverdi MH, Uzar E: Protective effects of beta glucan and glicazide on brain tissue and sciatic nerve of diabetic rats induced by streptozonin. Exp Diabetes Res. 2012, 2012: 230342-CrossRef
8.
go back to reference de Souza MO, Silva M, Silva ME, Oliveira Rde P, Pedrosa ML: Diet supplementation with acai (Euterpe oleracea Mart.) pulp improves biomarkers of oxidative stress and the serum lipid profile in rats. Nutrition. 2010, 26: 804-810. 10.1016/j.nut.2009.09.007.CrossRef de Souza MO, Silva M, Silva ME, Oliveira Rde P, Pedrosa ML: Diet supplementation with acai (Euterpe oleracea Mart.) pulp improves biomarkers of oxidative stress and the serum lipid profile in rats. Nutrition. 2010, 26: 804-810. 10.1016/j.nut.2009.09.007.CrossRef
9.
go back to reference Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW: Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr. 1989, 49: 1155-1163. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW: Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr. 1989, 49: 1155-1163.
10.
go back to reference Mayes PA: Intermediary metabolism of fructose. Am J Clin Nutr. 1993, 58: 754S-765S. Mayes PA: Intermediary metabolism of fructose. Am J Clin Nutr. 1993, 58: 754S-765S.
11.
go back to reference Bezerra RM, Ueno M, Silva MS, Tavares DQ, Carvalho CR, Saad MJ: A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J Nutr. 2000, 130: 1531-1535. Bezerra RM, Ueno M, Silva MS, Tavares DQ, Carvalho CR, Saad MJ: A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J Nutr. 2000, 130: 1531-1535.
12.
go back to reference Reeves PG, Nielsen FH, Fahey GC: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition and hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993, 123: 1939-1951. Reeves PG, Nielsen FH, Fahey GC: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition and hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993, 123: 1939-1951.
13.
go back to reference Colégio Brasileiro de Experimentação Animal: Princípios éticos na experimentação animal do Colégio Brasileiro de Experimentação Animal. 1991, COBEA, São Paulo Colégio Brasileiro de Experimentação Animal: Princípios éticos na experimentação animal do Colégio Brasileiro de Experimentação Animal. 1991, COBEA, São Paulo
14.
go back to reference Bełtowski J, Wójcicka G, Mydlarczyk M, Jamroz A: Cerivastatin modulates plasma paraoxonase/arilesterase activity and oxidant-antioxidant balance in the rat. Pol J Pharmacol. 2002, 54: 143-150. Bełtowski J, Wójcicka G, Mydlarczyk M, Jamroz A: Cerivastatin modulates plasma paraoxonase/arilesterase activity and oxidant-antioxidant balance in the rat. Pol J Pharmacol. 2002, 54: 143-150.
15.
go back to reference Buege JA, Aust SD: Microsomal lipid peroxidation. Methods Enzymol. 1978, 52: 302-310.CrossRef Buege JA, Aust SD: Microsomal lipid peroxidation. Methods Enzymol. 1978, 52: 302-310.CrossRef
16.
go back to reference de Oliveira RB, de Paula DA, Rocha BA, Franco JJ, Gobbo-Neto L, Uyemura SA, dos Santos WF, Da Costa FB: Renal toxicity caused by oral use of medicinal plants: the yacon example. J Ethnopharmacol. 2011, 27: 434-441.CrossRef de Oliveira RB, de Paula DA, Rocha BA, Franco JJ, Gobbo-Neto L, Uyemura SA, dos Santos WF, Da Costa FB: Renal toxicity caused by oral use of medicinal plants: the yacon example. J Ethnopharmacol. 2011, 27: 434-441.CrossRef
17.
go back to reference Watson A, Berliner JA, Hama SY, La Du BN, Fuall KF, Fogelman AM, Navab M: Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest. 1995, 96: 2882-2891. 10.1172/JCI118359.CrossRef Watson A, Berliner JA, Hama SY, La Du BN, Fuall KF, Fogelman AM, Navab M: Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest. 1995, 96: 2882-2891. 10.1172/JCI118359.CrossRef
18.
go back to reference Shin MO, Moon JO: Effect of dietary supplementation of grape skin and seeds on liver fibrosis induced by dimethylnitrosamine in rats. Nutr Res Pract. 2010, 4: 369-374. 10.4162/nrp.2010.4.5.369.CrossRef Shin MO, Moon JO: Effect of dietary supplementation of grape skin and seeds on liver fibrosis induced by dimethylnitrosamine in rats. Nutr Res Pract. 2010, 4: 369-374. 10.4162/nrp.2010.4.5.369.CrossRef
19.
go back to reference Camps J, Marsillach J, Joven J: Measurement of serum paraoxonase-1 activity in the evaluation of liver function. World J Gastroenterol. 2009, 15: 1929-1933. 10.3748/wjg.15.1929.CrossRef Camps J, Marsillach J, Joven J: Measurement of serum paraoxonase-1 activity in the evaluation of liver function. World J Gastroenterol. 2009, 15: 1929-1933. 10.3748/wjg.15.1929.CrossRef
20.
go back to reference Busserolles J, Gueux E, Rock E, Demigné C, Mazur A, Rayssiguier Y: Oligofructose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats. J Nutr. 2003, 133: 1903-1908. Busserolles J, Gueux E, Rock E, Demigné C, Mazur A, Rayssiguier Y: Oligofructose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats. J Nutr. 2003, 133: 1903-1908.
21.
go back to reference D’Angelo G, Elmarakby AA, Pollock DM, Stepp DW: Fructose feeding increases insulin resistance but not blood pressure in Sprague–Dawley rats. Hypertension. 2005, 46: 806-811. 10.1161/01.HYP.0000182697.39687.34.CrossRef D’Angelo G, Elmarakby AA, Pollock DM, Stepp DW: Fructose feeding increases insulin resistance but not blood pressure in Sprague–Dawley rats. Hypertension. 2005, 46: 806-811. 10.1161/01.HYP.0000182697.39687.34.CrossRef
22.
go back to reference Rosenblat M, Karry R, Aviram M: Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. Atherosclerosis. 2006, 187: 74-81. Rosenblat M, Karry R, Aviram M: Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. Atherosclerosis. 2006, 187: 74-81.
23.
go back to reference Núñez J, Miñana G, Bodí V, Núñez E, Sanchis J, Husser O, Llàcer A: Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011, 18: 3226-3233. 10.2174/092986711796391633.CrossRef Núñez J, Miñana G, Bodí V, Núñez E, Sanchis J, Husser O, Llàcer A: Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011, 18: 3226-3233. 10.2174/092986711796391633.CrossRef
24.
go back to reference Bełtowski J, Wójcicka G, Mydlarczyk M, Jamroz A: The effect of peroxisome proliferator-activated receptors alpha (PPARalpha) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON1) activity. J Physiol Pharmacol. 2002, 53: 463-475. Bełtowski J, Wójcicka G, Mydlarczyk M, Jamroz A: The effect of peroxisome proliferator-activated receptors alpha (PPARalpha) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON1) activity. J Physiol Pharmacol. 2002, 53: 463-475.
Metadata
Title
Salt overload in fructose-fed insulin-resistant rats decreases paraoxonase-1 activity
Authors
Waleska Cláudia Dornas
Wanderson Geraldo de Lima
Rinaldo Cardoso dos Santos
Melina Oliveira de Souza
Maísa Silva
Mirla Fiuza Diniz
Marcelo Eustáquio Silva
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2012
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/1743-7075-9-63

Other articles of this Issue 1/2012

Nutrition & Metabolism 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine